Y
Yanti Octavia
Researcher at Maastricht University Medical Centre
Publications - 6
Citations - 1076
Yanti Octavia is an academic researcher from Maastricht University Medical Centre. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 2, co-authored 3 publications receiving 896 citations.
Papers
More filters
Journal ArticleDOI
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia,Carlo G. Tocchetti,Kathleen L. Gabrielson,Stefan Janssens,Harry J.G.M. Crijns,An L. Moens +5 more
TL;DR: The authors have reviewed the molecular mechanisms of the pathogenesis of acute and chronic doxorubicin-induced cardiotoxicity and propose potential pharmacological interventions and treatment options to prevent or reverse this specific type of heart failure.
Journal ArticleDOI
DNA repair in cardiomyocytes is critical for maintaining cardiac function in mice
Martine de Boer,Maaike te Lintel Hekkert,Jiang Chang,Bibi S. van Thiel,Leonie Martens,Maxime M Bos,Marion G J de Kleijnen,Yanto Ridwan,Yanti Octavia,Elza D. van Deel,Lau Blonden,Renata M. C. Brandt,Sander Barnhoorn,Paula K Bautista-Niño,Ilona Krabbendam-Peters,Rianne Wolswinkel,Banafsheh Arshi,Mohsen Ghanbari,Christian Kupatt,Leon J. De Windt,A.H. Jan Danser,Ingrid van der Pluijm,Carol Ann Remme,Monika Stoll,Joris Pothof,Anton J.M. Roks,Maryam Kavousi,Jeroen Essers,Jolanda van der Velden,Jan H.J. Hoeijmakers,Dirk J. Duncker +30 more
TL;DR: In this paper , the authors tested the hypothesis that endogenous DNA repair in cardiomyocytes is critical for maintaining normal cardiac function, so that perturbed repair of spontaneous DNA damage drives early onset of heart failure.
Journal ArticleDOI
Tackling reperfusion injury after cardiopulmonary bypass with tetrahydrobiopterin: new therapeutic potentials for this phenylketonuria drug?
TL;DR: More focused molecular analysis is needed to further unravel the mechanism of action and optimize the use of this eNOS-modulator (BH4), which is already approved as phenylketonuria (PKU) drug, in this clinical relevant model of reperfusion injury.
Journal ArticleDOI
Endothelial dysfunction after right coronary artery remodeling: a new pathogenetic role of eNOS uncoupling?
TL;DR: It is reported by using a swine model of pulmonary artery banding-induced right ventricular hypertrophy that the outward remodeling of the right coronary artery (RCA) induces reactive oxygen species (ROS) generation, an increase in basal activity.
Journal ArticleDOI
Cardiovascular Disease in Patients With Breast Cancer Treated in the Modern Era
Alexandra Murphy,Anoop N. Koshy,Omar Farouque,Belinda Yeo,L. Roccisano,Yanti Octavia,Matias B Yudi +6 more
TL;DR: In this article , the authors derived a BC cardiovascular risk index called the CRIB (Cardiovascular Risk Index in Breast Cancer) to estimate the risk of a major adverse cardiovascular events (MACE) in women undergoing treatment for BC.